EOLS stock forecast
Our latest prediction for Evolus, Inc.'s stock price was made on the June 3, 2019 when the stock price was at 14.17$.
In the short term (2weeks), EOLS's stock price should underperform the market by -0.68%. During that period the price should oscillate between -11.70% and +15.97%.
In the medium term (3months), EOLS's stock price should outperform the market by 0.10%. During that period the price should oscillate between -23.33% and +36.60%.Get email alerts
Create a solid portfolio with EOLS
About Evolus, Inc.
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November, 2012 and is headquartered in Newport Beach, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -3.21$ per share.
The book value per share is 1.42$
Three months stock forecastJune 3, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|